Full lobby transparency now!

Freiwillig mehr Transparenz

Publication date: 
Thursday, May 3, 2012
The European Policy Department of DNR (German League for Nature and Environment)

"Die EU Civil Society Contact Group und die Alliance for Lobbying Transparency and Ethics Regulation in the EU (ALTER-EU) haben im April einen Leitfaden zur Steigerung zur Transparenz im Lobbyregister der EU-Kommission und des Europäischen Parlaments veröffentlicht."

Bruxelles bat Washington sur son propre terrain

Publication date: 
Wednesday, April 18, 2012
Sylvestre Sbille
Media title: 

Cambrai a ses bêtises, Amsterdam ses coffee shops, et Zurich ses banques... La spécialité de Bruxelles n'est ni la dentelle ni le chocolat, mais le lobbying.

Lobbies: jusqu’où la transparence?

Publication date: 
Thursday, April 12, 2012
Thierry Denoël
Media title: 
Le Vif/L'Express

A l’occasion de la sortie du film The Brussels Business, nous avons enquêté sur les lobbies qui tournent autour des institutions européennes. Les efforts de régulation de ce secteur particulier commencent à porter leurs fruits. Mais la transparence reste un idéal.

How to make a transparent registration in the Joint European Commission & Parliament “Transparency Register”

Publication date: 
Tuesday, April 3, 2012
ALTER-EU and the EU Civil Society Contact Group

The EU Civil Society Contact Group and ALTER-EU criticise the “Transparency Register” as fundamentally flawed because it is not mandatory, it does not require organisations to register all individual lobbyists who work for them, and because the required financial reporting on lobbying expenditure is inconsistent and not comparable.

Document types: 

Pharmaceutical companies lobbying European Commission fail to declare activities to Transparency Register

Publication date: 
Wednesday, March 28, 2012
Health Action International - Europe, Corporate Europe Observatory

New research reveals that the pharmaceutical lobby is spending more than €40 million annually to influence decision making in the European Union (EU) – of which nearly half is spent by drug manufacturers on in-house lobbyists. A large share of the industry however, doesn't declare how much it spends.

Brussels: a lobbying paradise

Publication date: 
Tuesday, March 27, 2012
Will Dinan, Erik Wesselius
Media title: 

In the last 30 years, thousands of lobbyists have flocked to Brussels, drawn by the increasing importance of EU-level decision making. With over 15,000 lobbyists influencing the EU institutions, Brussels vies with Washington for the title of lobbying capital of the world.

Snapshot original article (pdf): 

'1 billion Euro worth of lobbying' - successful public debate in Copenhagen

Publication date: 
Monday, March 26, 2012
1 billion worth of lobbying
Start date: 
Wed, 2012-03-21 13:00
Wegeners Gård, conference room, Vesterbrogade 60 A, Copenhagen V

Finance lobbyists do everything in their power to prevent tighter rules for the financial sector in response to the financial crisis. Are they successful? ALTER-EU and DEO focused on corporate lobbying in the EU. Presentations were given by ALTER-EU spokespeople Olivier Hoedeman and Kenneth Haar.

Together with partner group DEO, ALTER-EU organised the successful public debate to which more than 80 people participated. Kenneth Haar held a presentation on the influence of the financial industry, highlighting ALTER-EU's work around the corporate capture of expert groups. Olivier Hoedeman focused on the lobbying battle around EU food labeling rules and presented ALTER-EU's ten key demands.

Afterwards a four-hour workshop ended with a panel debate featuring the chair of the Danish consumers' union, two industry lobbyists and MEP Søren Søndergaard.

Some photos and a summary in Danish can be found online here:



Subscribe to Full lobby transparency now!